Physician profile
David M Hirsch
NPI 1356340947
$3,019.39
in general payments reported to CMS, 2019-2025
25 companies · $426 in 2025
The $426 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $616 · 2020: $376 · 2021: $627 · 2022: $256 · 2023: $378 · 2024: $339 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,127 · Education: $16.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.35 |
| Education | $16.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $420.09 | 2019-2023 | Proclaim |
| Nevro Corp. | $379.54 | 2019-2024 | Senza |
| Scilex Pharmaceuticals INC. | $367.81 | 2021-2024 | Ztlido |
| Globus Medical, INC. | $298.58 | 2025 | Senza |
| Boston Scientific Corporation | $255.11 | 2019-2025 | Intracept |
| Pacira Therapeutics, INC. | $203.56 | 2019-2021 | |
| Amgen INC. | $184.79 | 2019-2022 | |
| Si-Bone, INC. | $160.59 | 2020-2021 | |
| Abbvie INC. | $115.66 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $107.29 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $92.53 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $60.75 | 2024-2025 | |
| Medtronic USA, INC. | $39.45 | 2020 | |
| Ibsa Pharma INC. | $35.82 | 2021 | |
| Horizon Therapeutics Plc | $35.10 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $32.23 | 2019 | |
| Curonix LLC | $32.08 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biodelivery Sciences International, INC. | $30.06 | 2021 | |
| Medtronic, INC. | $29.66 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $29.61 | 2023-2024 | Zilretta, Exparel |
| Zyla Life Sciences, INC. | $26.51 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $24.36 | 2020 | |
| Bioventus LLC | $22.82 | 2024 | Durolane |
| Fidia Pharma USA INC. | $19.36 | 2024 | Hymovis |
| Relievant Medsystems, INC. | $16.03 | 2023 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hirsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.